Brief: Lineage Cell Therapeutics May Offer And Sell Common Shares Of Up To $40 Million From Time To Time Through Or To B. Riley
March 22 (Reuters) - Lineage Cell Therapeutics Inc
LCTX.A :
* LINEAGE CELL THERAPEUTICS INC - MAY OFFER AND SELL COMMON
SHARES
OF UP TO $40 MILLION FROM TIME TO TIME THROUGH OR TO B. RILEY
Source text for Eikon: [ID:https://bitly.ws/3gAZq]
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million